Floatz logo

Dichlorphenamide

Hypokalemic Periodic Paralysis

National Center for Research Resources (NCRR)Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hypokalemic Periodic Paralysis cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Dichlorphenamide is also rated in:

hyperkalemic periodic paralysisDormant
BB
Indicative ·
64 / 100
View asset →
paramyotonia congenita of Von EulenburgDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →